PTPRJ and cancer: This study has investigated for the first time the biological effects of CD148 Q276P/R326Q polymorphisms in cancer cell proliferation, growth factor (EGF) signaling, and the CD148 ligand‐induced cancer cell growth inhibition by introducing WT and mutated (Q276P/R326Q) CD148 into A431D epidermoid cancer cells.